Stellate Ganglion Block in Longstanding Facial Nerve Palsy Patients
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorAssiut University
About this trial
The goal of the present study is to verify the efficacy of stellate ganglion block (SGB) in the treatment of facial pain
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
facial nerve palsy patients
Disqualifiers
light of a recent myocardial infarction.
anticoagulant use
glucoma
lateral nerve palsy
Trial population
facial nerve palsy patients
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Stellate Ganglion Block
DrugStellate ganglion block is an injection of local anesthetic at the level of the neck to target the stellate ganglion, a sympathetic ganglion to interrupt abnormal autonomically-mediated pain in patients resistant to medical treatment
Treatment groups
34 Participants
are divided into 2 treatment groupsGroup A: stellate ganglion block group1 intervention
Group B: medical treatment group0 interventions
Trial outcomes
Primary outcomes
1
Primary outcome: Average motor conduction latency in six muscle of the face
Time frame
6 monthSecondary outcomes
1
Improved muscle tone
facial muscles start to regain their strength improvement of muscle tone.
Time frame
6 monthsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: